MNPR
Price
$36.35
Change
+$0.14 (+0.39%)
Updated
Sep 4, 01:59 PM (EDT)
Capitalization
223.41M
SHJBF
Price
$1.97
Change
+$0.73 (+58.87%)
Updated
Dec 31 closing price
Capitalization
6.06B
Interact to see
Advertisement

MNPR vs SHJBF

Header iconMNPR vs SHJBF Comparison
Open Charts MNPR vs SHJBFBanner chart's image
Monopar Therapeutics
Price$36.35
Change+$0.14 (+0.39%)
Volume$100
Capitalization223.41M
SHANGHAI JUNSHI BIOSCIENCES
Price$1.97
Change+$0.73 (+58.87%)
Volume$150
Capitalization6.06B
MNPR vs SHJBF Comparison Chart in %
Loading...
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MNPR vs. SHJBF commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNPR is a Hold and SHJBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (MNPR: $36.21 vs. SHJBF: $1.97)
Brand notoriety: MNPR and SHJBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MNPR: 167% vs. SHJBF: 100%
Market capitalization -- MNPR: $223.41M vs. SHJBF: $6.06B
MNPR [@Biotechnology] is valued at $223.41M. SHJBF’s [@Biotechnology] market capitalization is $6.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MNPR’s FA Score shows that 0 FA rating(s) are green whileSHJBF’s FA Score has 1 green FA rating(s).

  • MNPR’s FA Score: 0 green, 5 red.
  • SHJBF’s FA Score: 1 green, 4 red.
According to our system of comparison, MNPR is a better buy in the long-term than SHJBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MNPR’s TA Score shows that 5 TA indicator(s) are bullish.

  • MNPR’s TA Score: 5 bullish, 5 bearish.

Price Growth

MNPR (@Biotechnology) experienced а +4.02% price change this week, while SHJBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.71%. For the same industry, the average monthly price growth was +5.90%, and the average quarterly price growth was +27.78%.

Industries' Descriptions

@Biotechnology (-0.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHJBF($6.06B) has a higher market cap than MNPR($223M). MNPR YTD gains are higher at: 64.591 vs. SHJBF (0.000).
MNPRSHJBFMNPR / SHJBF
Capitalization223M6.06B4%
EBITDA-19.11MN/A-
Gain YTD64.5910.000-
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash53.3MN/A-
Total Debt80.4KN/A-
TECHNICAL ANALYSIS
Technical Analysis
MNPRSHJBF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
4%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
5%
Advances
ODDS (%)
Bullish Trend 8 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MNPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EMEQ31.230.12
+0.37%
Macquarie Focused Emerging Mrkts Eq ETF
USG37.180.06
+0.16%
USCF Gold Strategy Plus Income Fund
JHPI22.930.03
+0.13%
JHancock Preferred Income ETF
EELV26.160.02
+0.08%
Invesco S&P Emerging Markets Low Vol ETF
MDYV83.32-0.16
-0.19%
SPDR® S&P 400 Mid Cap Value ETF

MNPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNPR has been loosely correlated with QNCX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MNPR jumps, then QNCX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
+6.72%
QNCX - MNPR
33%
Loosely correlated
+0.62%
CVKD - MNPR
28%
Poorly correlated
+3.71%
RAPT - MNPR
26%
Poorly correlated
-4.80%
NEUP - MNPR
25%
Poorly correlated
+8.79%
AGIO - MNPR
25%
Poorly correlated
+3.46%
More

SHJBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SHJBF has been loosely correlated with AUPH. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SHJBF jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHJBF
1D Price
Change %
SHJBF100%
N/A
AUPH - SHJBF
38%
Loosely correlated
+2.74%
UCBJF - SHJBF
30%
Poorly correlated
+1.40%
SRPT - SHJBF
28%
Poorly correlated
+4.35%
QRON - SHJBF
24%
Poorly correlated
N/A
MNPR - SHJBF
21%
Poorly correlated
+6.72%
More